Clinical Perspectives on the Best Approach to First-Line Therapy in Unresectable HCC
Do you use combination therapy for patients with unresectable hepatocellular carcinoma (HCC)?
Related Articles
Patient Information: Renal Cell Carcinoma
This JAMA Patient Page describes renal cell carcinoma and its risk factors, signs and symptoms, treatment, and prognosis.
Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists
This cross-sectional study evaluates the quality and accuracy of information presented on websites that sell compounded glucagon-like peptide-1 receptor agonists.
Innovaccer acquires Humbi AI, its 3rd acquisition in a year, to launch actuarial copilots
Healthcare technology company Innovaccer announced its acquisition of Humbi AI, an actuarial software, services and analytics company used by providers, payers and life sciences companies…
What went wrong at 23andMe? Why the genetic-data giant risks collapse
Nature – At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
Trump’s early moves signal rollbacks on drug costs, ACA coverage
President Donald Trump issued a flurry of executive orders and other actions on healthcare, signaling he intends to reverse many of Joe Biden’s moves.
Myths and truths about vitamin C – Harvard Health
While vitamin C may not prevent colds or shorten their duration, it does offer other health benefits. Discover foods rich in vitamin C to enhance…
What could be causing your itchy scalp? – Harvard Health
Struggling with an itchy scalp? Learn about common causes like dandruff, dry skin, or fungal infections, and find out how to get relief….
World’s first chatbot, ELIZA, resurrected from 60-year-old computer code
A small team of researchers from the U.S. and the U.K. has resurrected the code for a 60-year-old chatbot named ELIZA, believed to be the…
Blackrock Neurotech arrays used in BCI that enables finger-based control using only thought
Blackrock Neurotech announced that researchers used its microelectrode arrays to develop a high-performance brain-computer interface (BCI).
